262 related articles for article (PubMed ID: 19530895)
1. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
[TBL] [Abstract][Full Text] [Related]
2. Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
Cao S; Murphy BT; Foster C; Lazo JS; Kingston DG
Bioorg Med Chem; 2009 Mar; 17(6):2276-81. PubMed ID: 19028102
[TBL] [Abstract][Full Text] [Related]
3. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
[TBL] [Abstract][Full Text] [Related]
5. Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.
Johnston PA; Soares KM; Shinde SN; Foster CA; Shun TY; Takyi HK; Wipf P; Lazo JS
Assay Drug Dev Technol; 2008 Aug; 6(4):505-18. PubMed ID: 18699726
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
[TBL] [Abstract][Full Text] [Related]
7. Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1.
Lazo JS; Nunes R; Skoko JJ; Queiroz de Oliveira PE; Vogt A; Wipf P
Bioorg Med Chem; 2006 Aug; 14(16):5643-50. PubMed ID: 16698271
[TBL] [Abstract][Full Text] [Related]
8. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
Vogt A; Tamewitz A; Skoko J; Sikorski RP; Giuliano KA; Lazo JS
J Biol Chem; 2005 May; 280(19):19078-86. PubMed ID: 15753082
[TBL] [Abstract][Full Text] [Related]
9. A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells.
Vogt A; McDonald PR; Tamewitz A; Sikorski RP; Wipf P; Skoko JJ; Lazo JS
Mol Cancer Ther; 2008 Feb; 7(2):330-40. PubMed ID: 18245669
[TBL] [Abstract][Full Text] [Related]
10. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.
Lazo JS; Aslan DC; Southwick EC; Cooley KA; Ducruet AP; Joo B; Vogt A; Wipf P
J Med Chem; 2001 Nov; 44(24):4042-9. PubMed ID: 11708908
[TBL] [Abstract][Full Text] [Related]
11. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B.
George Rosenker KM; Paquette WD; Johnston PA; Sharlow ER; Vogt A; Bakan A; Lazo JS; Wipf P
Bioorg Med Chem; 2015 Jun; 23(12):2810-8. PubMed ID: 25703307
[TBL] [Abstract][Full Text] [Related]
13. Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.
Keinan S; Paquette WD; Skoko JJ; Beratan DN; Yang W; Shinde S; Johnston PA; Lazo JS; Wipf P
Org Biomol Chem; 2008 Sep; 6(18):3256-63. PubMed ID: 18802630
[TBL] [Abstract][Full Text] [Related]
14. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
[TBL] [Abstract][Full Text] [Related]
15. Cell-active dual specificity phosphatase inhibitors identified by high-content screening.
Vogt A; Cooley KA; Brisson M; Tarpley MG; Wipf P; Lazo JS
Chem Biol; 2003 Aug; 10(8):733-42. PubMed ID: 12954332
[TBL] [Abstract][Full Text] [Related]
16. Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.
Lazo JS; Skoko JJ; Werner S; Mitasev B; Bakan A; Koizumi F; Yellow-Duke A; Bahar I; Brummond KM
J Pharmacol Exp Ther; 2007 Sep; 322(3):940-7. PubMed ID: 17538006
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
Schepetkin IA; Karpenko AS; Khlebnikov AI; Shibinska MO; Levandovskiy IA; Kirpotina LN; Danilenko NV; Quinn MT
Eur J Med Chem; 2019 Dec; 183():111719. PubMed ID: 31563013
[TBL] [Abstract][Full Text] [Related]
18. Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening.
Bakan A; Lazo JS; Wipf P; Brummond KM; Bahar I
Curr Med Chem; 2008; 15(25):2536-44. PubMed ID: 18855677
[TBL] [Abstract][Full Text] [Related]
19. 2,4-Dihydroxychalcone derivatives as novel potent cell division cycle 25B phosphatase inhibitors and protein tyrosine phosphatase 1B inhibitors.
Xie C; Sun Y; Pan CY; Tang LM; Guan LP
Pharmazie; 2014 Apr; 69(4):257-62. PubMed ID: 24791588
[TBL] [Abstract][Full Text] [Related]
20. Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array.
Ducruet AP; Rice RL; Tamura K; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
Bioorg Med Chem; 2000 Jun; 8(6):1451-66. PubMed ID: 10896122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
